Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Pristanic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST001639 AN002683 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort Blood Human COPD National Jewish Health AU
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University ion counts
ST002152 AN003524 Metabolomics analysis of mouse liver with or without SIRT5 deficiency Liver Mouse North Carolina State University ion counts
ST002829 AN004621 Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study Blood Human COVID-19 National Institutes of Health log transformed data
ST001940 AN003155 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003156 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003157 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001940 AN003158 Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement Feces Human Irritable bowel syndrome University of California, Los Angeles Metabolon original scale
ST001412 AN002362 Metabolomics study in Plasma of Obese Patients with Neuropathy Identifies Potential Metabolomics Signatures Blood Human Obesity University of Michigan Peak area
ST001441 AN002408 Metabolomics of patient-derived fibroblasts Fibroblast cells Human Mitochondrial disease North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University Peak area
ST001749 AN002850 REACH Metabolomics Study Blood Human Alzheimers disease University of Wisconsin - Madison Raw area counts
ST002818 AN004588 Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) Blood Human Tufts Medical Center raw area counts rescaled to set the median equal to 1
ST002088 AN003408 Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema Blood Human COPD National Jewish Health relativeMedian
ST002017 AN003287 Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) Blood Human Vanderbilt University Medical Center scaled imputed
ST002019 AN003289 TIPs Metabolomics (blood) Blood Human Vanderbilt University Medical Center scaled imputed
  logo